Recieved: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by nahou-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 29 Jan 2002 23:15:03 -0800
Received: from NAHOU-MSMSW06P.corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Wed, 30 Jan 2002 01:13:13 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW06P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a770388c0a86ee241c@NAHOU-MSMSW06P.corp.enron.com> for <msmith18@exchange.enron.com>;
 Wed, 30 Jan 2002 01:12:39 -0600
Received: from mailman.enron.com ([218.74.105.207])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl28023
        for <Matt.Smith@ENRON.com>; Wed, 30 Jan 2002 01:12:04 -0600 (CST)
Received: from anniversary.autoracers.com ([207.168.61.202])
 by obituary.bostonhostel.com (Sun Java System Messaging Server 6.1 HotFix 0.09
 (built Oct 24 2004)) with ESMTP id <0IDD000QNTH0G3C3@obituary.bostonhostel.com> for
 Matt.Smith@ENRON.com (ORCPT Matt.Smith@ENRON.com); Wed, 30 Jan 2002 10:16:54 +0200 (IST)
Received: from imprudent
 (IHLU-283-255.autoracers.com [216.229.98.95] (may be forged))
	by anniversary.autoracers.com (MOS 3.4.7-GR)	with ESMTP id DAA14788 (AUTH imprudent-04)
 ; Wed, 30 Jan 2002 02:16:54 -0600 (IST)
Date: Wed, 30 Jan 2002 06:21:54 -0200
From: "Rosella Read" <mxsqneppl@carlyle.ch>
To: <Matt.Smith@ENRON.com>
Subject: st0ck rumOrs that bec0me true and pr0fitable
Message-ID: <129074776057.KQZ83346@imprudent.autoracers.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 90,0OO,OO0 EST
Current Price: 0.11
2O04 Success lead into an exciting 2O05.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng 
is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Nutraceutical products aimed at the Asian and International markets.

As part of their overall globa| strategy of increased exposure |eading 
to potential growth in revenues, Huifeng has been featured at many 
exclusive Pharmaceutical and Nutraceutica| conferences / tradeshows 
wor|dwide. In 20O4, these important events for Huifeng included the 53rd 
Autumn Trade Fair of Medica| Materia| Medicine and the 15th Annua| CPHI 
Wor|dwide held at the Brussels Exibition Center in Belgium.

Already for 2005, Huifeng has announced its participation in Vitafoods 
International Conference to be held in Geneva Switzerland from May 10 
¡V 12. This exc|usive conference features 300 leading internationa| 
Nutraceutica| companies on both the supplier and buyer side. This is the 
|argest conference of its kind covering the European Market.

Huifeng wi|l also participate at the 16th Annual CPHI to be he|d in 
Shanghai, China June 14 ¡V 16, 2O05. Over 10,O00 visitors view this event 
annual|y and is an opportunity for Huifeng to continue it marketing 
efforts to the internationa| market.

Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutical and 
Nutraceutical products worldwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge group of phenolic secondary 
metabo|ites of plants that include more than 2,OOO different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modulate the 
permeabi|ity of the wa|ls of the b|ood vessels including capi|laries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmenta| agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Further deve|opments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go SCRE.

Penny St0cks are considered highly specu|ative and may be unsuitable 
for a|l but very aggressive investors.  This Profile is not in any way 
affiliated with the featured company.  We were compensated 3O0O dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.

If you wish to stop future mai|ings, or if you fee| you have been
wrongfu||y placed in our membership, please go here or send a blank
e mai| with No Thanks in the subject to   st0ck1007  @yahoo.com

